Noninvasive methods for predicting the recurrence of atrial fibrillation (AF) after initial pulmonary vein isolation (PVI) have not been well described. The aim of the present study was to evaluate the usefulness of the P-wave signal-averaged electrocardiogram (P-SAECG) in predicting the recurrence of AF after initial PVI. The P-SAECG was recorded before and after (within 1 week) the initial PVI session. The filtered P-wave duration (FPD) and root mean square voltage of the last 20 ms of the filtered P-wave (LP20) were measured in 87 consecutive idiopathic AF patients (ejection fraction ≥50%, Btype natriuretic peptide ≤200 pg/mL). During the follow-up period (12 ± 7 months), 22 of 87 (25%) patients had recurrence of AF (11 with paroxysmal AF and 11 with persistent AF). In the group with recurrence of paroxysmal AF, the post-PVI FPD was significantly shorter and the post-PVI LP20 was significantly larger than in the non-recurrence group. Furthermore, the post-PVI LP20/FPD ratio was significantly higher in the group with paroxysmal AF recurrence 3 that in the non-recurrence group (0.024 ± 0.009 vs 0.015 ± 0.007 μV/ms, respectively; P < 0.05). Recurrence of paroxysmal AF was more frequently observed in patients with a post-PVI LP20/FPD >0.015 μV/ms than in those with a post-PVI LP20/FPD ≤0.015 μV/ms.
Introduction
Atrial fibrillation (AF) is the most frequently encountered arrhythmia in clinical practice, occurring in 1%-2% of the general population. 1 The pulmonary veins (PVs) play an important role in both the initiation and maintenance of AF. 2, 3 Recently, PV isolation (PVI) has been shown to be effective for curing paroxysmal and persistent AF. 4, 5 Furthermore, PVI for paroxysmal AF results in the maintenance of sinus rhythm (SR) without any antiarrhythmic drugs in 70%-90% of patients. 6 However, AF recurs in 10%-30% of patients after successful PVI. The recurrence rate is higher in patients with structural heart disease 7 or prolonged AF duration, such as persistent AF. 8 Persistent AF has been shown to lead to atrial interstitial fibrosis, resulting in an increased atrial conduction time. 9 This structural remodeling, in addition to electrophysiological remodeling such as a shortening or loss of the rate adaptation of the atrial refractory period 10 or prolonged atrial conduction times, 11, 12 may increase the recurrence of AF after PVI. The signal-averaged electrocardiogram (SAECG) is a simple non-invasive method that has been used for years, initially to evaluate ventricular late potentials, but now extended to the P-wave to provide a more accurate evaluation of atrial conduction. Many studies have used this method to evaluate reductions in P-wave duration to predict the recurrence of 5 AF after PVI. 13, 14 In a previous report, 14 patients with recurrence of AF after PVI, short filtered P-wave duration (FPD) and elevation of root mean square voltage of the last 20 ms of the filtered P-wave (LP20) are sometimes recorded. In these cases, the P-wave SAECG (P-SAECG) was recorded within 1 week after PVI; however, in a previous report 13 the day of recording P-SAECG was not clear. Based on these observations, we thought that the FDP and LP20 within 1 week after PVI may be different from those reported in previous studies. 13, 14 Thus, the aim of the present study was to evaluate the usefulness of P-SAECG within 1 week after the initial PVI to establish a new parameter of the recurrence of AF after the initial PVI.
Materials and Methods

Study population
The present study was a retrospective analysis of consecutive patients with AF. From April 2008 to November 2012, 87 consecutive 6 patients (67 males, 20 females; mean [± SD] age 60 ± 12 years) who underwent an initial PVI session for paroxysmal (n = 65) or persistent (n = 22) AF in the Division of Cardiology, Department of Medicine, Showa University School of Medicine were evaluated. In the present study, paroxysmal AF was defined as AF terminating within 7 days, and persistent AF was defined as non-self-terminating AF lasting more than 7 days and requiring pharmacologic or electrical conversion to restore SR. Patients were excluded from the study if the P-SAECG was not appropriately recorded. Other exclusion criteria were as follows: structural heart disease, prior PVI, implanted pacemaker, mitral or aortic valve disease, left ventricular dysfunction (left ventricular ejection fraction (LVEF) <50%), and congestive heart failure (plasma B-type natriuretic peptide (BNP) concentrations >200 pg/mL). P-SAECG was recorded before and after (within 1 week) the initial PVI in all patients.
Signal-Averaged P-Wave Electrocardiography Figure 1 shows an example of a P-SAECG. This P-SAECG was recorded in the P-wave-triggered mode (FDX-6500; Fukuda Denshi Co., Tokyo, Japan). The P-wave signals (>200 beats) were recorded from a standard 12-lead electrocardiogram (ECG) until the noise amplitude was reduced to <0.4 μV. The signal from Lead II was filtered bidirectionally (with forward and backward filters) through a filter setting of 60 Hz, and a backward filter was used for the analysis in the present study. The filtered signals from Leads I, aVF, and V1
were combined into a vector magnitude of the P-wave. The FPD and LP20 were measured and the ratio LP20/FPD was calculated.
Measurements of FPD and LP20 were made automatically and, if Non-Re vs. Persis-Re, and the significance of differences in continuous variables was determined using Student's unpaired t-test, whereas the χ 2 or Fischer's exact test was used in comparisons of categorical data. To obtain an index of the overall FPD and RMS20 in the patients with and without recurrence of paroxysmal AF, a receiver operating characteristic (ROC) curve was generated and the area under the curve was calculated. The AF-free rates in the patients with an LP20/FPD ≦ 0.015 μV/ms and > 0.015 μV/ms were calculated using the Kaplan-Meier method, and the difference between them was detected using the log-rank test. The duration of AF, left atrial dimension, LVEF, (of which the P values were less than 0.05 using the Student's t-test and χ 2 test) were evaluated by the Cox's multivariate regression analysis. Statistical significance was accepted at a P < 0.05. Where appropriate, data are given as the mean ± SD.
Results
Clinical Characteristics
The clinical characteristics of patients in the Non-Re, Paroxy-Re, and Persis-Re groups are given in Table 1 . There were no significant 
Signal-Averaged P-Wave Electrocardiography
There were no significant differences in FPD and LP20 before PVI between the Non-Re and Paroxy-Re or Persis-Re groups (pre-PVI FPD 134 ± 11.6 vs. 125 ± 11.5 and 149 ± 9.0 ms, respectively; Fig. 2A ).
Conversely, the post-PVI FPD in the Paroxy-Re group was significantly shorter than in the Non-Re group (123 ± 9.1 vs. 131 ± 11.7 ms, respectively; P < 0.05; Fig. 2B ). The post-PVI LP20 in the Paroxy-Re group was significantly larger than in the Non-Re group (2.9 ± 1.1 vs. 2.0 ± 0.9 μV, respectively; P < 0.05; Fig. 2B ). There was no significant difference in the pre-PVI LP20/FPD between the NonRe and Paroxy-Re groups (0.018 ± 0.011 vs. 0.02 ± 0.007 μV/ms, respectively; Fig. 3A ), but there was a significant difference in the LP20/FPD ratio between these two groups after the initial PVI (0.015 ± 0.007 vs. 0.024 ± 0.009 μV/ms, respectively; P < 0.05; Fig. 3B ).
Predictors of AF Recurrence
To evaluate the total predictive performance of the post-PVI LP20, post-PVI FPD, and post-PVI LP20/FPD for predicting Paroxy-Re, receiver operating characteristic (ROC) analyses were performed, revealing that the post-PVI LP20/FPD was a more useful predictor of Paroxy-Re than either the post-PVI FPD or post-PVI LP20 (Fig. 4A ).
The optimal post-PVI LP20/FPD cut-off value of 0.015 μV/ms had a sensitivity of 90% and a specificity of 60%. Figure 4B shows the AF- The clinical characteristics of patients with a post-PVI LP20/FPD ≤0.015 μV/ms (n = 41) or >0.015 μV/ms (n = 35) are given in Table 2 .
There were no significant differences in the age, gender, duration of AF, LVEF, BNP, CHADS2 score, and CHA2DS2-VASc score between patients with a post-PVI LP20/FPD of ≤0.015 and >0.015 μV/ms.
However, hypertension was significantly more frequent in the group with post-PVI LP20/FPD >0.015 μV/ms (n = 23) than in the group with post-PVI LP20/FPD ≤0.015 μV/ms (n = 16; P < 0.05; Table 2 ).
Discussion
The present is the first to describe the usefulness of the post-PVI recurrence during the follow-up period had a significant reduction in FPD (from 161 ± 7 to 151 ± 8 ms; ΔFPD 10 ± 7 ms; P < 0.0001),
whereas there was no significant shortening in FPD in patients with AF recurrence (ΔFPD 2 ± 9 ms; P = NS). A cut-off value of ≥5 ms for the reduction in the P-wave had a sensitivity of 92% and a specificity of 71% to predict a good clinical outcome. For that reason, shortening of the FPD after PVI was reported to be a predictor of successful AF ablation. 16, 17 In the present study, the results were opposite to those reported in these previous studies. We suppose that shorting of the FPD after PVI in the present study may be due to the complete electrical isolation of all four PVs at the time of the PVI session.
However, during the follow-up period, there was a reconnection of the electrical conduction between the PV and LA in some patients. We suppose that other factors are needed to predict the electrical reconnection of PVs.
The P-SAECG is useful for identifying individuals at risk of developing AF and those likely to change from paroxysmal to chronic AF. 18 Previous studies have shown that patients with chronic AF have a lower LP20 than those with paroxysmal AF. 19 However, the usefulness of the LP20 for the prediction of AF recurrence after PVI was not proved. Ogawa et al. 14 performed computer simulation studies using a realistic 3D atrial activation model, and the results confirmed a reduction in P-wave duration and changes in the terminal portion of the P-wave morphology after simulated PVI.
These findings suggest that the PV muscle sleeves are responsible for the terminal portion of the P-wave, and contribute to the late potentials on the P-SAECG. Furthermore, Ogawa et al. 14 documented that the LP20 increased significantly after the PVI procedure, both in patients with either successful or failed ablation. Therefore, the LP20
was not proven as a useful parameter for prognostication after AF ablation. However, in the present study, in the case of only those patients with paroxysmal AF recurrence (the study population was limited to idiopathic AF patients with LVEF ≥50% and BNP ≤200 pg/mL), the post-PVI LP20 was significantly larger than in patients without recurrence, and these results proved that the LP20 was a useful parameter for the prediction of recurrence of paroxysmal AF after PVI.
The notable finding of the present study is that the shorter FPD and larger LP20 after initial PVI were significantly associated with a Patients with a post-PVI LP20/FPD >0.015 μV/ms had a higher risk of recurrence of paroxysmal AF than those with a post-PVI LP20/FPD ≤0.015 μV/ms (P = 0.027, log-rank test). 
